Replies to post #102704 on Biotech Values

[BTH]

I don't know why it worked better than nexavar

It worked better than Nexavar because Nexavar is another crap MULTI-TARGETED Kinase inhibitor.

[rkrw]

PLX4032 was designed to target a very specific mutation, the BRAF v600e mutation, they screen patients for this mutation.

It's not a matter of nexavar being a crappy multi kinase drug (to quote BTH's flippant remark), nexavar wasn't designed to hit that mutation.